Lower incidence of Bronchiolitis obliterans in allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning compared with myeloablative conditioning

S. Yoshihara, U. Tateishi, T. Ando, H. Kunitoh, H. Suyama, Y. Onishi, Ryuji Tanosaki, S. Mineishi

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Bronchiolitis obliterans (BO) is one of the most devastating complications after allogeneic stem cell transplantation (HSCT). However, its true pathogenesis is still to be elucidated. We conducted this study to find whether tissue damage due to high-dose chemo-radiotherapy is related to its pathogenesis. In all, 144 patients who received allogeneic HSCT between May 1999 and October 2001, and survived more than 80 days after transplant, were analyzed. Clinical course, pulmonary function tests, imaging studies including CT scan, and pathology results were reviewed. The overall incidence of BO was 9.7% (14/144). The cumulative incidence of BO at 2 years after transplant was 17% with myeloablative conditioning, and 2.3% with reduced intensity conditioning (P=0.024). Multivariate analysis showed that myeloablative conditioning was the only factor which affected the incidence of BO. Development of BO did not significantly affect the overall survival of patients. However, if they developed BO earlier than 200 days post transplant, the prognosis was significantly worse than if they developed it later than 200 days post transplant (P = 0.003) or if they did not develop BO (P = 0.002). Our results imply that tissue damage secondary to intensive chemo-radiotherapy may contribute to the pathogenesis of BO.

Original languageEnglish
Pages (from-to)1195-1200
Number of pages6
JournalBone Marrow Transplantation
Volume35
Issue number12
DOIs
Publication statusPublished - 2005 Jun
Externally publishedYes

Fingerprint

Bronchiolitis Obliterans
Hematopoietic Stem Cell Transplantation
Incidence
Transplants
Radiotherapy
Respiratory Function Tests
Stem Cell Transplantation
Multivariate Analysis
Pathology
Survival

Keywords

  • Allogeneic stem cell transplantation
  • Bronchiolitis obliterans (BO)
  • Reduced intensity

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Lower incidence of Bronchiolitis obliterans in allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning compared with myeloablative conditioning. / Yoshihara, S.; Tateishi, U.; Ando, T.; Kunitoh, H.; Suyama, H.; Onishi, Y.; Tanosaki, Ryuji; Mineishi, S.

In: Bone Marrow Transplantation, Vol. 35, No. 12, 06.2005, p. 1195-1200.

Research output: Contribution to journalArticle

@article{a081297ab63141a19596bd9dd57f8880,
title = "Lower incidence of Bronchiolitis obliterans in allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning compared with myeloablative conditioning",
abstract = "Bronchiolitis obliterans (BO) is one of the most devastating complications after allogeneic stem cell transplantation (HSCT). However, its true pathogenesis is still to be elucidated. We conducted this study to find whether tissue damage due to high-dose chemo-radiotherapy is related to its pathogenesis. In all, 144 patients who received allogeneic HSCT between May 1999 and October 2001, and survived more than 80 days after transplant, were analyzed. Clinical course, pulmonary function tests, imaging studies including CT scan, and pathology results were reviewed. The overall incidence of BO was 9.7{\%} (14/144). The cumulative incidence of BO at 2 years after transplant was 17{\%} with myeloablative conditioning, and 2.3{\%} with reduced intensity conditioning (P=0.024). Multivariate analysis showed that myeloablative conditioning was the only factor which affected the incidence of BO. Development of BO did not significantly affect the overall survival of patients. However, if they developed BO earlier than 200 days post transplant, the prognosis was significantly worse than if they developed it later than 200 days post transplant (P = 0.003) or if they did not develop BO (P = 0.002). Our results imply that tissue damage secondary to intensive chemo-radiotherapy may contribute to the pathogenesis of BO.",
keywords = "Allogeneic stem cell transplantation, Bronchiolitis obliterans (BO), Reduced intensity",
author = "S. Yoshihara and U. Tateishi and T. Ando and H. Kunitoh and H. Suyama and Y. Onishi and Ryuji Tanosaki and S. Mineishi",
year = "2005",
month = "6",
doi = "10.1038/sj.bmt.1704985",
language = "English",
volume = "35",
pages = "1195--1200",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "12",

}

TY - JOUR

T1 - Lower incidence of Bronchiolitis obliterans in allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning compared with myeloablative conditioning

AU - Yoshihara, S.

AU - Tateishi, U.

AU - Ando, T.

AU - Kunitoh, H.

AU - Suyama, H.

AU - Onishi, Y.

AU - Tanosaki, Ryuji

AU - Mineishi, S.

PY - 2005/6

Y1 - 2005/6

N2 - Bronchiolitis obliterans (BO) is one of the most devastating complications after allogeneic stem cell transplantation (HSCT). However, its true pathogenesis is still to be elucidated. We conducted this study to find whether tissue damage due to high-dose chemo-radiotherapy is related to its pathogenesis. In all, 144 patients who received allogeneic HSCT between May 1999 and October 2001, and survived more than 80 days after transplant, were analyzed. Clinical course, pulmonary function tests, imaging studies including CT scan, and pathology results were reviewed. The overall incidence of BO was 9.7% (14/144). The cumulative incidence of BO at 2 years after transplant was 17% with myeloablative conditioning, and 2.3% with reduced intensity conditioning (P=0.024). Multivariate analysis showed that myeloablative conditioning was the only factor which affected the incidence of BO. Development of BO did not significantly affect the overall survival of patients. However, if they developed BO earlier than 200 days post transplant, the prognosis was significantly worse than if they developed it later than 200 days post transplant (P = 0.003) or if they did not develop BO (P = 0.002). Our results imply that tissue damage secondary to intensive chemo-radiotherapy may contribute to the pathogenesis of BO.

AB - Bronchiolitis obliterans (BO) is one of the most devastating complications after allogeneic stem cell transplantation (HSCT). However, its true pathogenesis is still to be elucidated. We conducted this study to find whether tissue damage due to high-dose chemo-radiotherapy is related to its pathogenesis. In all, 144 patients who received allogeneic HSCT between May 1999 and October 2001, and survived more than 80 days after transplant, were analyzed. Clinical course, pulmonary function tests, imaging studies including CT scan, and pathology results were reviewed. The overall incidence of BO was 9.7% (14/144). The cumulative incidence of BO at 2 years after transplant was 17% with myeloablative conditioning, and 2.3% with reduced intensity conditioning (P=0.024). Multivariate analysis showed that myeloablative conditioning was the only factor which affected the incidence of BO. Development of BO did not significantly affect the overall survival of patients. However, if they developed BO earlier than 200 days post transplant, the prognosis was significantly worse than if they developed it later than 200 days post transplant (P = 0.003) or if they did not develop BO (P = 0.002). Our results imply that tissue damage secondary to intensive chemo-radiotherapy may contribute to the pathogenesis of BO.

KW - Allogeneic stem cell transplantation

KW - Bronchiolitis obliterans (BO)

KW - Reduced intensity

UR - http://www.scopus.com/inward/record.url?scp=21244505810&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21244505810&partnerID=8YFLogxK

U2 - 10.1038/sj.bmt.1704985

DO - 10.1038/sj.bmt.1704985

M3 - Article

VL - 35

SP - 1195

EP - 1200

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 12

ER -